Troubled Grubhub’s Parent Company Seeks Investment Partner: WSJ

Dutch multinational online food ordering and delivery company Just Eat Takeaway.com NV (OTC: TKAYF) is hit by doubts about whether it can sell its U.S. operation, Grubhub Inc. As per Wall Street Journal, Grubhub CEO Adam DeWitt said the company’s parent hopes to find a strategic partner, though a divestiture cannot be ruled out. In some … Full […]

Merck/Seagen Potential Deal Talks Pick Up Speed: WSJ

Merck & Co Inc (NYSE: MRK) is pushing forward with a potential deal for Seagen Inc (NASDAQ: SGEN), Wall Street Journal reported, citing people familiar with the matter. The Journal mentioned that the deal could be one of the largest takeovers of the year. The Wall Street Journal reported last week that Merck was in talks to buy Seagen, which […]

Apple’s Expected New 15-Inch Macbook: What We Know So Far

Apple Inc (NASDAQ: AAPL) has long been rumored to launch a larger version of its Macbook Air. In this article, we will review all that we know about this upcoming device. What Happened: The latest version of the Macbook Air has a 13.6 inches screen, but rumors say the newer model is significantly larger at 15 inches. That would […]

SVB Leerink’s Pro-forma Analysis Of Speculated Merck/Seagen Deal – What Investors Need To Know

SVB Securities conducted a pro-forma analysis of the financial impact to Merck & Co Inc (NYSE: MRK) from a potential acquisition of Seagen Inc (NASDAQ: SGEN). The analysts refrain from commenting on the probability of the deal happening. The analysis suggests that the short-term impact on EPS from the potential acquisition will likely be meaningfully dilutive. Related: Merck Shows Takeover Interest […]

Merck Shows Takeover Interest In Seagen: WSJ

Merck & Co Inc (NYSE: MRK) is reportedly mulling buying cancer-focused biotech Seagen Inc (NASDAQ: SGEN), Wall Street Journal reported citing people familiar with the matter. If the deal happens, it would be significant, given Seagen’s market value of roughly $28 billion. According to the report, some people said … Full story available on Benzinga.com Read More

Why Mereo BioPharma Shares Are Jumping Today

AstraZeneca plc (NASDAQ: AZN) is rumored to be eyeing take over of Mereo BioPharma Group plc (NASDAQ: MREO), according to a report in The Times. The Times’ report says that “Mereo would accept $5, equating to $500 million including American depositary receipts or ADRs. Evercore and Citigroup are said to be involved as advisers.” Mereo’s lead drug, a TIGIT […]